• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC.(CRM-SYLMAR) FORTIFY ASSURA VR ICD_IDE_US; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC.(CRM-SYLMAR) FORTIFY ASSURA VR ICD_IDE_US; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number CD1257-40Q
Medical Device Problem Code Premature Discharge of Battery (1057)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/31/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device is included in the battery performance alert advisory issued by abbott on 28 august 2017.
 
Event or Problem Description
Following the battery performance alert (bpa) advisory, a bpa was received by the clinician and awaiting explant.Further information was requested, but not yet available.Further information was requested, however was not provided.
 
Event or Problem Description
New information noted that the device was explanted and replaced.The patient was stable post procedure.
 
Additional Manufacturer Narrative
Premature battery depletion was confirmed by analysis.A device evaluation was performed, and no sources of high currents were noted.The cause of the premature battery depletion was consistent with li cluster formation.From these analyses, in the absence of a high current draw, it is probable that the premature battery depletion was caused by a lithium cluster-induced short circuit.Li clusters are a known depletion mechanism for these advisory products that have been investigated and associated with a field action in october 2016.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FORTIFY ASSURA VR ICD_IDE_US
Common Device Name
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
Manufacturer (Section G)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
Manufacturer Contact
richard williamson
15900 valley view court
sylmar, CA 91342
MDR Report Key16211801
Report Number2017865-2023-02653
Device Sequence Number14566410
Product Code NVZ
UDI-Device Identifier05414734505475
UDI-Public05414734505475
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P910023
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2012
Device Explanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2013
Device Model NumberCD1257-40Q
Device Catalogue NumberCD1257-40Q
Device Lot Number3696911
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/31/2022
Supplement Date Received by Manufacturer01/19/2023
03/02/2023
Initial Report FDA Received Date01/19/2023
Supplement Report FDA Received Date02/08/2023
03/03/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/25/2012
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-0003-2018;Z-0115-2017
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age57 YR
Patient SexMale
-
-